We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$999B
AUM Growth
+$24.7B
Cap. Flow
-$14B
Cap. Flow %
-1.41%
Top 10 Hldgs %
24.27%
Holding
2,908
New
248
Increased
1,171
Reduced
1,334
Closed
66

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$3.3B
2
LLY icon
Eli Lilly
LLY
+$2.75B
3
AZN icon
AstraZeneca
AZN
+$1.98B
4
CPNG icon
Coupang
CPNG
+$1.54B
5
FTNT icon
Fortinet
FTNT
+$1.48B

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$2.34B
2
MS icon
Morgan Stanley
MS
+$2.26B
3
ABNB icon
Airbnb
ABNB
+$2.04B
4
QCOM icon
Qualcomm
QCOM
+$1.95B
5
NVDA icon
NVIDIA
NVDA
+$1.81B

Sector Composition

Rank Sector Weight
1 Technology 23.35%
2 Healthcare 16.19%
3 Consumer Discretionary 15.55%
4 Financials 12.84%
5 Communication Services 12.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIGL icon
2726
Rigel Pharmaceuticals
RIGL
$782M
$150K ﹤0.01%
4,395
+3,234
+279% +$128K
APRN
2727
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$150K ﹤0.01%
+1,983
New +$198K
SELF
2728
Global Self Storage
SELF
$58.6M
$149K ﹤0.01%
31,399
OVID icon
2729
Ovid Therapeutics
OVID
$489M
$148K ﹤0.01%
+36,748
New +$122K
LYTS icon
2730
LSI Industries
LYTS
$890M
$147K ﹤0.01%
17,288
+5,119
+42% +$47.7K
PR
2731
Permian Resources
PR
$18B
$147K ﹤0.01%
34,900
AIOT
2732
PowerFleet Inc
AIOT
$421M
$147K ﹤0.01%
17,943
+5,175
+41% +$42.7K
MBT
2733
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$147K ﹤0.01%
17,600
-362,700
-95% -$3.19M
AP icon
2734
Ampco-Pittsburgh
AP
$190M
$146K ﹤0.01%
+21,600
New +$158K
ROCC
2735
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$146K ﹤0.01%
10,864
-2,300
-17% -$31.6K
AKBA icon
2736
Akebia Therapeutics
AKBA
$248M
$144K ﹤0.01%
42,674
-69
-0.2% -$249
IDN icon
2737
Intellicheck
IDN
$74.7M
$142K ﹤0.01%
+16,915
New +$198K
ZYNE
2738
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$142K ﹤0.01%
30,500
KRRO icon
2739
Korro Bio
KRRO
$197M
$141K ﹤0.01%
297
+135
+83% +$262K
NG icon
2740
NovaGold Resources
NG
$3.45B
$141K ﹤0.01%
16,056
+18
+0.1% +$164
LCI
2741
DELISTED
Lannett Company, Inc.
LCI
$139K ﹤0.01%
+6,588
New +$174K
PBYI icon
2742
Puma Biotechnology
PBYI
$459M
$136K ﹤0.01%
14,025
-16
-0.1% -$179
LPCN icon
2743
Lipocine
LPCN
$17M
$135K ﹤0.01%
+5,251
New +$152K
RESN
2744
DELISTED
Resonant Inc.
RESN
$135K ﹤0.01%
+31,778
New +$171K
STIM icon
2745
Neuronetics
STIM
$223M
$134K ﹤0.01%
+10,800
New +$166K
ARC
2746
DELISTED
ARC Document Solutions, Inc.
ARC
$134K ﹤0.01%
63,502
JAGX icon
2747
Jaguar Health
JAGX
$3.73M
0
SEAC
2748
DELISTED
Seachange International Inc
SEAC
$131K ﹤0.01%
4,219
-915
-18% -$23.3K
PZN
2749
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$128K ﹤0.01%
12,129
+95
+0.8% +$894
INFI
2750
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$127K ﹤0.01%
39,200

Similar funds

T. Rowe Price Associates's Q1 2021 Portfolio in Review

As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
  • T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
  • T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
  • T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
  • T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
  • T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
  • T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.

Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.